Page last updated: 2024-08-22

nimorazole and Carcinoma, Anaplastic

nimorazole has been researched along with Carcinoma, Anaplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berthelsen, A; Jørgensen, K; Lindeløv, B; Overgaard, J; Overgaard, M; Rasmusson, B; Sand Hansen, H	1

Trials

1 trial(s) available for nimorazole and Carcinoma, Anaplastic

Article	Year
Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1991, Volume: 20 Suppl 1 Topics: Carcinoma; Combined Modality Therapy; Denmark; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Male; Nimorazole; Radiation-Sensitizing Agents	1991

Article

Year

Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1991, Volume: 20 Suppl 1

Topics: Carcinoma; Combined Modality Therapy; Denmark; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Male; Nimorazole; Radiation-Sensitizing Agents

1991